Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Imlunestrant's trials
EMBER-4
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
Imlunestrant
Ongoing
Active not recruiting
Phase 3
Open NCT05514054 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
EMBER-4 · Trial Tracker · ComplyRx
